Copyright: ©Author(s) 2026.
World J Virol. Mar 25, 2026; 15(1): 114321
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.114321
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.114321
Table 5 Risk factors for cytomegalovirus infection in liver transplantation recipients
| Risk factors of CMV infection in LT patients |
| CMV sero-negative status |
| High dose maintenance immunosuppression |
| Use of lymphocyte depleting agents like anti-thymocyte globulin, alemtuzumab and muromonab |
| LT recipients more than kidney transplant recipients |
| Donor/recipient advanced age |
| Human leukocyte antigen mismatch |
| Immediate graft rejection |
| Impaired humoral immunity |
| Co-infection with other herpes virus |
- Citation: Praharaj DL, Giri S, Anand AC, Mallick B, Nath P, Sahu SK, Pattnaik B, Acharya SK, Chawla YK. Viral hepatitis after liver transplantation: A brief overview. World J Virol 2026; 15(1): 114321
- URL: https://www.wjgnet.com/2220-3249/full/v15/i1/114321.htm
- DOI: https://dx.doi.org/10.5501/wjv.v15.i1.114321